CME: Critical Care Pharmacotherapy Literature Update - (June 2012)
ACCREDITATION EXPIRED: June 21, 2014
Activity Description / Statement of Need:
In this online CME self-learning program:
This is a monthly review of select articles in the medical literature pertaining to pharmacotherapy used in
critically ill patient populations. The content below is for information purposes only and is intended to
highlight recent articles that may be of interest to those caring for patients in various intensive care or
related settings. Though some core content from the publications is presented, the reader is encouraged
to review each article in full for additional detail in order to fully interpret the study, its findings, and its
applicability to practice.
Target Audience:
This program has been designed for a multidisciplinary physician, nurse, and pharmacist audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is NOT supported by any commercial support.
Release Date: June 21, 2012 -- Expiration Date: June 21, 2014
Faculty: Charles Turck, PharmD, BCPS
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Be able to describe the study: Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort
- Be able to describe the study: Active surveillance cultures of methicillin-resistant S. Aureus ventilator-associated pneumonia
- Be able to describe the study: Antibiotic Strategies in Severe Nosocomial Sepsis: Why Do We Not De-Escalate More Often?
- Be able to describe the study: Macrolide Antibiotics and Survival in Patients with Acute Lung Injury
- Be able to describe the study: Safety of Early Warfarin Resumption Following Burr Hole Drainage for Warfarin-Associated Subacute or Chronic Subdural Hemorrhage
Accreditation
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Disclosures of Faculty / Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from Bayer, Edwards Lifesciences, Eisai, Daiichi-Sankyo, Lilly, Merck, Pfizer, Sanofi Aventis.
This program is NOT supported by any commercial support.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.